affluentmedical

A screengrab from a video demonstration of the Artus device. [Image from Affluent Medical]Affluent Medical today announced the successful first-in-human implant of its minimally invasive urinary incontinence treatment device.

Dr. Roman Zachoval completed the first implant of Artus, an artificial urinary sphincter. Zachoval, head of urology at Thomayer University Hospital in Prague, implanted Artus in a 68-year-old male patient with severe urinary incontinence.

The procedure lasted about 80 minutes and went according to plan, according to a news release. Affluent Medical plans to activate the device six weeks after implantation, after the surgical wound healing process.

“Artus is easy to prepare and implant due to its innovative design compared to the previous generation of urinary sphincters. With the positioning of the cuff around the urethra and the implantation of the control unit the different steps of the implantation were straightforward,” Zacho…

The Epygon mitral valve. [Image from Affluent Medical]Affluent Medical today announced positive findings in a clinical evaluation of its Epygon device for replacing mitral valves.

The Aix-en-Provence, France-based company designed Epygon to replace mitral valves in those with mitral insufficiency. Epygon is the first biomimetic transcatheter mitral valve to mimic the native mitral valve and restore the natural vortex of blood flow in the left ventricle, according to a news release. The transcatheter implant process enables a fast, minimally invasive procedure that helps avoid open-heart surgery.

Epygon is the first biomimetic transcatheter mitral valve to mimic the native mitral valve and restore the natural vortex of blood flow in the left ventricle. Its transcatheter implantation makes it a fast and minimally invasive procedure, avoiding open heart surgery.

Transcatheter mitral valve replacement (TMVR) is growing in popularity. Both Medtronic (Intrepid) a…